|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03759 PHARMARON
Nominal 
17.300 -0.820 (-4.525%) Ranking Overview
Ranking based on 8 research report(s)
Average Ranking 2.38
|
Strong Buy (1)
0
|
Buy (2)
6
|
Hold (3)
1
|
Sell (4)
1
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2022 | EPS | 77.50 RMB (cts) | |
| Net Profit | 1,374.60 RMB (MIL) | DPS | -- RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2023 | 1,744.00 | 97.50 | 19.02 | -- | 2,060.67 | 1,548.00 |
| 2024 | 2,250.50 | 126.33 | 24.70 | -- | 2,829.09 | 1,848.00 |
| 2025 | 3,064.00 | 171.50 | 25.11 | -- | 3,608.14 | 2,283.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2023 | 2,060.67 | 115.33 | -- | JEFFERIES HK | Buy | 30.67 | 14/04/2023 | |
| 2023 | 1,774.00 | 99.30 | 21.30 | BOCI | Buy | 37.00 | 01/08/2023 | |
| 2023 | 1,635.00 | 91.51 | -- | NOMURA | Buy | 36.24 | 23/07/2023 | |
| 2023 | 1,749.00 | 98.00 | -- | MORGAN STANLEY | Equal-weight | 23.43 | 05/06/2023 | |
| 2023 | 1,910.00 | 107.00 | 24.40 | BANK OF AMERICA | Buy | 30.40 | 28/08/2023 | |
| 2023 | 1,678.00 | 94.00 | -- | CLSA | Buy | 27.00 | 28/08/2023 | |
| 2023 | 1,739.00 | 97.00 | 25.00 | CICC | OutPerform | 24.80 | 30/07/2023 | |
| 2023 | 1,548.00 | 80.00 | 16.74 | MACQUARIE | UnderPerform | 16.00 | 28/08/2023 | |
| 2024 | 2,829.09 | 158.67 | -- | JEFFERIES HK | -- | -- | 14/04/2023 | |
| 2024 | 2,438.00 | 136.40 | 29.30 | BOCI | -- | -- | 01/08/2023 | |
| 2024 | 2,172.00 | 122.00 | -- | NOMURA | -- | -- | 23/07/2023 | |
| 2024 | 2,329.00 | 130.67 | -- | MORGAN STANLEY | -- | -- | 05/06/2023 | |
| 2024 | 2,525.00 | 141.00 | 30.50 | BANK OF AMERICA | -- | -- | 28/08/2023 | |
| 2024 | 2,061.00 | 115.00 | -- | CLSA | -- | -- | 28/08/2023 | |
| 2024 | 2,157.00 | 121.00 | 31.00 | CICC | -- | -- | 30/07/2023 | |
| 2024 | 1,848.00 | 100.00 | 20.09 | MACQUARIE | -- | -- | 28/08/2023 | |
| 2025 | 3,608.14 | 202.00 | -- | JEFFERIES HK | -- | -- | 14/04/2023 | |
| 2025 | 3,064.00 | 171.50 | 36.90 | BOCI | -- | -- | 01/08/2023 | |
| 2025 | 2,861.00 | 160.00 | -- | NOMURA | -- | -- | 23/07/2023 | |
| 2025 | 3,209.00 | 179.33 | -- | MORGAN STANLEY | -- | -- | 05/06/2023 | |
| 2025 | 3,214.00 | 180.00 | 38.10 | BANK OF AMERICA | -- | -- | 28/08/2023 | |
| 2025 | 2,616.00 | 146.00 | -- | CLSA | -- | -- | 28/08/2023 | |
| 2025 | 2,283.00 | 130.00 | 25.11 | MACQUARIE | -- | -- | 28/08/2023 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 04/10/2023 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 786,093 |
| %Change | 34.276% |
| EPS / (LPS) | RMB 0.444 |
| NBV Per Share (¥) | RMB 6.345 |